FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation. [electronic resource]
- Journal of immunology (Baltimore, Md. : 1950) Aug 1994
- 1836-46 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0022-1767
Animals Bone Marrow Transplantation--immunology Cyclosporine--pharmacology Female Graft Rejection--prevention & control Graft vs Host Disease--prevention & control Histocompatibility Lymphocyte Activation--drug effects Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Inbred DBA T-Lymphocytes--immunology Tacrolimus--pharmacology